UPAYA PEMERINTAH DAERAH KABUPATEN LOMBOK TENGAH UNTUK MEMPERCEPAT LAJU VAKSINASI COVID-19 DALAM RANGKA PERSIAPAN PELAKSANAAN MOTO GP DI PERTAMINA MANDALIKA INTERNATIONAL STREET CIRCUIT

Fanila Kasmita Kusuma

Abstract


Indonesia is holding the World Superbike (WorldSBK) which will take place from 19-21 November 2021 in Mandalika, Central Lombok, West Nusa Tenggara (NTB). In order for the event to run without causing anxiety in the midst of the Covid-19 pandemic, the government has intensified the Covid-19 vaccination for all people of Central Lombok until before the event starts. However, public trust in vaccines is still very lacking. This study aims to analyze the efforts of the Central Lombok regional government in accelerating the rate of Covid-19 vaccination in preparation for the implementation of the Moto GP at the Pertamina Mandalika International Street Circuit. So in its efforts, the Central Lombok regional government made an approach to increase public confidence in vaccination for the good of life in preventing the spread of Covid-19. In addition, the government has proposed several strict conditions for this event. Teams of race participants must quarantine for at least 5 days. And at least 70 percent of the total population of Central Lombok has been vaccinated. The government also gave instructions to the organizers of the World Superbike to form a special health protocol task force for supervision at the event location and provide masks for free.


Keywords


Vaccination, Local Government, Pertamina GP

Full Text:

PDF

References


Bish,A. etal. (2011), “Factors associated with uptake of vaccination against pandemic influenza: A systematic review”, Vaccine, Vol.29/38, pp.6472-6484, http://dx.doi.org/10.1016/j.vaccine.2011.06.107.

Blastland,M. etal. (2020), “Five rules for evidence communication”, Nature, Vol.587/7834, pp.362-364, http://dx.doi.org/10.1038/d41586-020-03189-1.

Bowers,S. and D.Cohen (2018), “How lobbying blocked European safety checks for dangerous medical implants”, BMJ363, https://doi.org/10.1136/bmj.k4999.

Brewer,N. and K.Fazekas (2007), “Predictors of HPV vaccine acceptability: A theory-informed, systematic review”, Preventive Medicine, Vol.45/2-3, pp.107-114, http://dx.doi.org/10.1016/j.ypmed.2007.05.013.

Buell,R. (2019), Operational Transparency, https://hbr.org/2019/03/operational-transparency.

Centers for Disease Control and Prevention (2021), Rapid Community Assessment Guide: Understand your community’s needs regarding COVID-19 vaccines, https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence/rca-guide/.

Chapman,G. and E.Coups (1999), “Predictors of Influenza Vaccine Acceptance among Healthy Adults”, Preventive Medicine, Vol.29/4, pp.249-262,http://dx.doi.org/10.1006/pmed.1999.0535.

Cinelli,M. etal. (2020), “The COVID-19 social media infodemic”, Scientific Reports, Vol.10/16598, http://dx.doi.org/doi.org/10.1038/s41598-020-73510-5.

de Figueredo,A. etal. (2020), “Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study”, The Lancet, Vol.396/10255, pp.898-908, http://dx.doi.org/10.1016/S0140-6736(20)31558-0.

ECDC (2020), Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK, https://www.ecdc.europa.eu/sites/default/files/documents/Overview-of-EU_EEA-UK-vaccination-deployment-plans.pdf

Eiser,J. etal. (2009), ““Trust me, I’m a Scientist (Not a Developer)”: Perceived Expertise and Motives as Predictors of Trust in Assessment of Risk from Contaminated Land”, Risk Analysis, Vol.29/2, http://dx.doi.org/10.1111/j.1539-6924.2008.01131.x.[39]EMA (2020), COVID-19 vaccines: development, evaluation, approval and monitoring, https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/covid-19-vaccines-development-evaluation-approval-monitoring.

Evans,W. and J.French (2021), “Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing”, Vaccines, Vol.9/4, p.319, http://dx.doi.org/10.3390/vaccines9040319.

Gagneur,A. etal. (2018),“Promoting Vaccination at Birth Using Motivational Interviewing Techniques Improves Vaccine Intention: The PromoVac Strategy”, Journal of Infectious Diseases and Therapy, Vol.6/5, pp.1–7, http://dx.doi.org/10.4172/2332-0877.1000379.

Giacalone,R. and J.Greenberg (1997), Antisocial behavior in organizations, Sage Publications.

Halabi,S., A.Heinrich and S.Omer (2020), “No-Fault Compensation for Vaccine Injury —The Other Side of Equitable Access to Covid-19 Vaccines”, New England Journal ofMedicine, Vol.383/23, p.e125, http://dx.doi.org/10.1056/nejmp2030600.

Hordijk,L. and P.Patnaik (2020), “Covid-19: EU countries spent over €220m stockpiling remdesivir despite lack of effectiveness, finds investigation”, BMJ, p.m4749, http://dx.doi.org/10.1136/bmj.m4749.

Ipsos (2021), Global Attitudes on a COVID-19 Vaccine: Ipsos survey for The World Economic Forum, https://www.ipsos.com/sites/default/files/ct/news/documents/2021-03/global-attitudes-on-a-covid-19-vaccine-march-2021-report_.pdf.

Johnson Shen,M. etal. (2018), “The Effects of Race and Racial Concordance on Patient-Physician Communication: A Systematic Review of the Literature”, Journal of racial and ethnic health disparities5, pp.117-140, http://dx.doi.org/10.1007/s40615-017-0350-4.

Junk,W. etal. (2020), Interest Representation during the Corona Virus Crisis: Results from the European Union and Nine European Countries. Summary Report, University of Copenhagen, University of Amsterdam, Trinity College Amsterdam, https://61b80c4f-58c1-4b9d-bce6-c58106af2ef4.filesusr.com/ugd/9a0cb4_dda8dac6e4e04e7fa88d30caab8b95a3.pdf

Kantar (2021), COVID-19 vaccine faces an increasingly hesitant public, https://www.kantar.com/inspiration/coronavirus/covid-19-vaccine-faces-an-increasingly-hesitant-public

Lind,E. etal. (2000), “The winding road from employee to complainant: Situational and psychological determinants of wrongful-termination claims”, Administrative science quarterly, Vol.45/3, pp.557-590, http://dx.doi.org/10.2307/2667109

Lundh,A. etal. (2017), “Industry sponsorship and research outcome”, in Lundh,A. (ed.), Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.MR000033.pub3.

Lunn,P. (2014), Regulatory Policy and Behavioural Economics, OECD Publishing, Paris, https://dx.doi.org/10.1787/9789264207851-en.

McAuliffe,K. etal. (2017), “The developmental foundations of human fairness”, Nature Human Behaviour, Vol.1/2, http://dx.doi.org/10.1038/s41562-016-0042.[59]Meppelinka,C. etal. (2019), ““I was Right about Vaccination”: Confirmation Bias and Health Literacy in Online Health Information Seeking”, Journal of Health Communication, Vol.24/2, pp.129-140, http://dx.doi.org/10.1080/10810730.2019.1583701.

Milkman,K. etal. (2011), “Using implementation intentions prompts to enhance influenza vaccination rates”, Proceedings of the National Academy of Sciences of the United States of America, Vol.108/26, pp.10415-10420, http://dx.doi.org/10.1073/pnas.1103170108.

Mindell,J. etal. (2012), “All in this together: the corporate capture of public health”, BMJ345, https://doi.org/10.1136/bmj.e8082.[19]Mondal,A. (2021), “The importance of community engagement on COVID-19 vaccination strategy: Lessons from two California pilot programs”, EClinicalMedicine, Vol.32, p.100754, http://dx.doi.org/10.1016/j.eclinm.2021.100754.

Murphy,J. etal. (2021), “Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom”, Nature Communications, Vol.12/29, pp.12-29, http://dx.doi.org/10.1038/s41467-020-20226-9.

Murtin,F. etal. (2018), “Trust and its determinants:Evidence from the Trustlab experiment”, OECD Statistics Working Papers, No.2018/2, OECD Publishing, Paris, https://dx.doi.org/10.1787/869ef2ec-en.

National Academies of Sciences, Engineering, and Medicine (2020), Framework for Equitable Allocation of COVID-19 Vaccine, The National Academies Press, https://doi.org/10.17226/25917.




DOI: https://doi.org/10.33758/mbi.v16i3.1409

Refbacks

  • There are currently no refbacks.


____________________________________________
MEDIA BINA ILMIAH

ISSN 1978-3787 (print) | 2615-3505( online)
Published by BINA PATRIA | Email: laloemipa@gmail.com

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 

View My Stats